These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6724830)

  • 1. Leukopenia with different regenerated haemodialysis membranes.
    Ksiaźek A; Sokołowska G; Marczewski K; Solski J
    Int Urol Nephrol; 1984; 16(1):61-7. PubMed ID: 6724830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility of haemodialysis membranes: haemodialysis-related leukotriene B4 and C4 generation. France.
    Hornych A; Rémy P; Luong N; Aumont J; Bariéty J
    Nephron; 1996; 74(1):11-8. PubMed ID: 8883014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in haemodialysis: a comparison of new and re-used dialysers.
    Levett DL; Woffindin C; Bird AG; Hoenich NA; Ward MK; Kerr DN
    Int J Artif Organs; 1986 Mar; 9(2):97-104. PubMed ID: 3699916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylonitrile.
    Bergesio F; Monzani G; Manescalchi F; Boccabianca I; Passaleva A; Frizzi V
    Blood Purif; 1988; 6(1):16-26. PubMed ID: 3345242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukopenia, hypoxia, and complement function with different hemodialysis membranes.
    Jacob AI; Gavellas G; Zarco R; Perez G; Bourgoignie JJ
    Kidney Int; 1980 Oct; 18(4):505-9. PubMed ID: 7230613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E; Montandon A; Nydegger U; Descoeudres C
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodialysis-induced leucopenia and activation of complement: effects of different membranes.
    Aljama P; Bird PA; Ward MK; Feest TG; Walker W; Tanboga H; Sussman M; Kerr DN
    Proc Eur Dial Transplant Assoc; 1978; 15():144-53. PubMed ID: 740661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials.
    Hakim RM; Lowrie EG
    Nephron; 1982; 32(1):32-9. PubMed ID: 6817150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis-induced hypoxemia: membrane dependent and membrane independent causes.
    Francos GC; Besarab A; Burke JF; Peters J; Tahamont MV; Gee MH; Flynn JT; Gzesh D
    Am J Kidney Dis; 1985 Mar; 5(3):191-8. PubMed ID: 3919574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
    Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
    Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of haemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers.
    Mulvihill J; Crost T; Renaux JL; Cazenave JP
    Nephrol Dial Transplant; 1997 Sep; 12(9):1968-73. PubMed ID: 9306352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodialysis leucopenia as an index of membrane biocompatibility.
    Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
    Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrylonitrile membranes.
    Seyfert UT; Helmling E; Hauck W; Skroch D; Albert W
    Nephrol Dial Transplant; 1991; 6(6):428-34. PubMed ID: 1876284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
    Stuard S; Bonomini M; Settefrati N; Albertazzi A
    Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodialysis-induced respiratory changes.
    Fawcett S; Hoenich NA; Laker MF; Schorr W; Ward MK; Kerr DN
    Nephrol Dial Transplant; 1987; 2(3):161-8. PubMed ID: 3114675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of blood compatibility of haemodialysis membranes using a miniature flat sheet dialyser.
    Mwaniki DL; Courtney JM; Forbes CD; Paul JP
    East Afr Med J; 1992 Mar; 69(3):149-52. PubMed ID: 1505404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membranes.
    Sultan Y; London GM; Goldfarb B; Toulon P; Marchais SJ
    Nephrol Dial Transplant; 1990; 5(5):362-8. PubMed ID: 2142756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.